Oxford BioMedica (OTCMKTS:OXBDF) Shares Gap Down – Here’s Why
by Danessa Lincoln · The Markets DailyOxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s stock price gapped down before the market opened on Monday . The stock had previously closed at $8.17, but opened at $7.4380. Oxford BioMedica shares last traded at $7.4380, with a volume of 800 shares.
Oxford BioMedica Stock Performance
The firm has a 50-day moving average price of $9.58 and a two-hundred day moving average price of $9.02.
Oxford BioMedica Company Profile
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.